Los Angeles-based Eyenuk, which makes AI-powered eye screening tech to detect diabetic retinopathy, raised a $26M Series A, bringing its total funding to $43M+ (Katie Adams/MedCity News)
Katie Adams / MedCity News:Los Angeles-based Eyenuk, which makes AI-powered eye screening tech to detect diabetic retinopathy, raised a $26M Series A, bringing its total funding to $43M+ — Eyenuk, a company that makes technology for eye screenings, raised $26 million in a Series A funding round, bringing its total funding to more than $43 million.
Landwebs
0
1
Katie Adams / MedCity News:
Los Angeles-based Eyenuk, which makes AI-powered eye screening tech to detect diabetic retinopathy, raised a $26M Series A, bringing its total funding to $43M+ — Eyenuk, a company that makes technology for eye screenings, raised $26 million in a Series A funding round, bringing its total funding to more than $43 million.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/IIH75AUMSFL4XLBRSJA2CEMEDI.jpg)
